We use cookies to optimise our website and our service.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
2 Comments on “Medical-review-pdf-V10”
Would these devices be appropriate for people with severe sleep apnea which cannot be effectively controlled with a BiPAP device? I imagine that they would not available now while being tested. They would probably be very expensive, also. Are you doing any trials in the United States?
Hi Kathy,
Thank you for your interest in Exovent.
There are many reasons for sleep apnea. It may be possible that this device may benefit some forms of sleep apnea such as central sleep apnea. It is less likely to help with obstructive sleep apnea.
The device will be available in Europe by the end of 2022 and is initially designed for hospital use. The intent is for there to be further developments for devices which are more affordable and available for home use.
We are focusing on Europe prior to release in the USA. Breath Global who are a US-Canadian organisation are developing a negative pressure device called Venti focussing on the US and Canada.